Amgen Inc.
Fc VARIANTS
Last updated:
Abstract:
Disclosed are Fc-containing proteins comprising a binding region and a variant Fc region that can elicit one or more immune effector function and/or bind to an Fc receptor more effectively than a similar Fc-containing protein comprising a wild type Fc region. Also disclosed are nucleic acids encoding such Fc-containing proteins, methods for making such proteins, and methods of treatment utilizing such proteins.
Status:
Application
Type:
Utility
Filling date:
16 May 2019
Issue date:
9 Jan 2020